Neoadjuvant radiotherapy
Neoadjuvant radiotherapy is a radiation therapy with 21 clinical trials. Currently 9 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
10
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
9
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
Neoadjuvant Radiation in Locally Advanced Breast Cancer
Three Fraction Radiation to Induce Immuno-Oncologic Response
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
Clinical Trials (21)
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
Neoadjuvant Radiation in Locally Advanced Breast Cancer
Three Fraction Radiation to Induce Immuno-Oncologic Response
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer
Neoadjuvant Radiotherapy for High-risk UTUC
Breast Reconstruction and Neoadjuvant Radiotherapy
Neoadjuvant Radiotherapy for Breast Cancer
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test.
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer
Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 21